Heart Alert Quandary Kiran K. Cheruku, MD Interventional Cardiologist Heart And Vascular Institute of Texas.

Slides:



Advertisements
Similar presentations
Part I: STEMI BootCamp The 5 “R’s” of Reperfusion”
Advertisements

Chapter 3 for 12 Lead Training -Precourse-
A Pharmaco-invasive Reperfusion Strategy with Immediate Percutaneous Coronary Intervention is Safe and Effective in ST-Elevation Myocardial Infarction.
EMS and D2B in Pennsylvania Douglas F. Kupas, MD, FACEP Commonwealth EMS Medical Director Bureau of EMS PA Department of Health.
Regional AMI Care: Bridging the Rural Health Care Gap Darren B. Bean, MD University of Wisconsin Emergency Medicine/Medflight Director UW Level 1 Heart.
The Macstrak Project ER Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
Relationship of Time to Treatment and Door-to-Balloon Time to Mortality in Patients with Acute Myocardial Infarction Treated with Primary Angioplasty Christopher.
An Immediate Nursing Feedback Program for Primary PCI for ST-segment Elevation Myocardial Infarction Karen Mckenny RN, Theresa Fortner RN, Cheryl McNeil.
STEMI: What’s the Rush? STEMI: What’s the Rush? William Phillips, MD, FACC, FSCAI Director of Cardiology CMMC A PCI Center perspective.
TOTAL Stroke in the TOTAL trial: Randomized trial of manual aspiration Thrombectomy in STEMI TOTAL Trial Investigators.
Very Rapid Treatment of STEMI: Utilizing Pre-Hospital ECGs to Bypass the Emergency Department Kenneth W. Baran, MD Medical Director for United Hospital’s.
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
Time Is Myocardium and the Wavefront of Necrosis CM Gibson 2002.
GUSTO I GUSTO I Median Time (hrs) Between Symptom Onset and Treatment GUSTO III GUSTO III InTIME II InTIME II ASSENT.
The New Washington State Emergency Cardiac and Stroke System: Developing a Best Practice Plan for Your Community Bev McCullough Quality Improvement Manager,
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.
ACS and Thrombosis in the Emergency Setting
AMI Strategy How to Achieve Door-to-Balloon Times of 90 Minutes and What to Do Next? Aaron Kugelmass, MD Director, Cardiac Cath Lab Associate Division.
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
1 Primary Angioplasty for Acute STEMI Dr Adam Jacques Dr Sola Odemuyiwa February 2010.
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
Role of Percutaneous coronary intervention (PCI) after thrombolytic therapy By Dr. Mohamed Mahros Assistant lecturer of cardiology Benha faculty of medicine.
“The Doctor said another 5 minutes and I would have been dead” A regional approach to saving heart muscle Vanessa Thornton Clinical Head Emergency Care.
ACTION Registry-GWTG Results: January 1, 2009 – December 31, 2009.
Management Of AMI Does time matter?? What is the best strategy: PPCI Vs TT.
STEMI/STROKE BOOT CAMP “Time is Muscle” Paul T. Frantz, MD Medical Director, Cardiac Services Carilion Clinic.
Patient Transfer Mark de Belder The James Cook University Hospital Middlesbrough.
Virginia Heart Attack Coalition/Mission Lifeline.
Which Early ST-Elevation Myocardial Infarction Therapy (WEST) Trial Paul W. Armstrong, WEST Steering Committee Published in The European Heart Journal.
Our STEMI Program Leesa Wright, RN, CCCC, CCRN
Rescue Angioplasty versus Conservative Therapy or Repeat Thrombolysis Trial Presented at American Heart Association Scientific Sessions 2004 Presented.
The INT egrelin and E noxaparin R andomized assessment of A cute C oronary syndrome Treatment T rial Sponsored by the Canadian Heart Research Centre, Key.
Eddy Lang MD Attending Staff Emergency Department Jewish General Hospital Update in reperfusion therapy for acute myocardial infarction.
The Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction (ASSENT-4 PCI) Trial ASSENT- 4 PCI Trial Presented.
West Hertfordshire Primary Angioplasty Service Masood Khan.
High-Dose, Double-Bolus Eptifibatide (Integrilin™) in Non- Urgent Coronary Stent Intervention 6 Month Results of the ESPRIT Trial.
TIMI 10A Protocol Design TNK- tPA Bolus ASA + IV Heparin (APTT 55-85) Follow-up Hosp. Discharge to 30 days Pt. with Acute MI < 12h End Points: Pharmacokinetics.
Proof of Concept #1: Occluded Arteries Cause Acute MI Proof of Concept #1: Occluded Arteries Cause Acute MI Proof of Concept #2: Drugs (in this case IC.
Inter-Hospital Transfer of High Risk STEMI Patients for PCI is Safe and Feasible David M. Larson, Katie M. Menssen, Scott W. Sharkey, Marc C. Newell, Anil.
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007.
RACE: Reperfusion of acute myocardial infarction in North Carolina emergency departments Christopher Granger, MD Director, Cardiac Care Unit Duke University.
VBWG OASIS-6 The Sixth Organization to Assess Strategies in Acute Ischemic Syndromes trial.
Acute Myocardial Infarction February 8, 2006.
S. Chiu Wong MD, FACC Associate Professor of Medicine Weill Medical College of Cornell University Director, Cardiac Catheterization Laboratories The New.
{ Challenging Case Presentations From South Texas Methodist Hospital REGIONAL SYSTEMS OF CARE DEMONSTRATION PROJECT: MISSION: LIFELINE™ STEMI SYSTEMS ACCELERATOR.
High-risk ST elevation MI patients (>4 mm elevation), Sx < 12 hrs 5 PCI centers (n=443) and 22 referring hospitals (n=1,129), transfer in < 3 hrs High-risk.
SPEED : GUSTO-IV PILOT GUSTO-IV Pilot Trial. SPEED : GUSTO-IV PILOT Rationale for Combination Therapy in AMI Enhance Incidence and Speed of Reperfusion.
Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction (ASSENT-4 PCI) Trial ASSENT- 4 PCI Trial Presented at.
James J. Augustine, MD DISCLOSURES
CRT 2015 Unmet Needs in STEMI Interventions
Challenging Case Presentations From South Texas Methodist Hospital
Optimising STEMi Care- Role of Nurses and Paramedics
The Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel
ASSENT-3 PLUS 1,639 patients with STEMI Treatment Group A
The European Society of Cardiology Presented by Dr. Saman Rasoul
The DANAMI-2 Trial Danish Trial in Acute Myocardial Infarction-2
Randomized Comparison in the Setting of Acute MI
American College of Cardiology Presented by Dr. Michel R. Le May
What oral antiplatelet therapy would you choose?
Circulation 2001;104: Circulation 2001;104:
OHSU Chest Pain Program
Maintenance of Long-Term Clinical Benefit with
European Heart Journal Advance Access
DANAMI 3-DEFER Trial design: Patients presenting with STEMI and in whom the operators could establish TIMI 2-3 flow without stenting or those presenting.
Atlantic Cardiovascular Patient Outcomes Research Team
INTRO AMI. INTEGRILIN AND. REDUCED DOSE. OF THROMBOLYTIC IN. ACUTE
GUSTO 1 Trial 41,000 patients enrolled, landmark study
Presentation transcript:

Heart Alert Quandary Kiran K. Cheruku, MD Interventional Cardiologist Heart And Vascular Institute of Texas

Mr. W is a 76 yr old caucasian male with Pmhx of HTN and GERD was travelling through San Antonio. Staying at a RV park, while working on his trailer developed chest pain 10/10. Took 2 s/l ntg with no relief. Severely nauseated and diaphoretic. Wife called 911.

911 call was placed at 09:33. EMS dispatched at 09:34 EMS arrived at scene 09:37 Found patient in severe distress with 10/10 worst chest pain in life, clutching his chest. Vitals signs showed BP 148/84 mmHg, P – 63 mmHg. One more s/l ntg was given with no relief.

EKG done in field at 09:43 am. Heart Alert activated at 09:44 am. EKG transmission attempted but unsuccessfull

NE Methodist notified of the Heart Alert and patient transported to NEM as it was the closest hospital. Patient arrived at NE Methodist at 09:54 am

Patient stable on arrival, but still in pain, 6/10. NE Methodist had another Heart Alert come in 15 minutes earlier and that patient was on the cath lab table. Only one team available as it was a weekend. WHAT TO DO NOW?

Thrombolytics Vs transfer to nearest PPCI center

9 High-risk ST elevation MI patients (>4 mm elevation), Sx < 12 hrs 5 PCI centers (n=443) and 22 referring hospitals (n=1,129), transfer in < 3 hrs Lytic therapy Front-loaded tPA 100 mg (n=782) Death / MI / Stroke at 30 Days DANAMI-2: Study Design Primary PCI with transfer (n=567) Primary PCI without transfer (n=223) Stopped early by safety and efficacy committee

10 Death / MI / Stroke (%) Lytic Primary PCI P= P=0.002 Combined Transfer Sites P=0.048 Non-Transfer Sites DANAMI-2: Primary Results RRR 45% Lytic Primary PCI Lytic Primary PCI RRR 40% RRR 45%

11 Lytic Primary PCI P=0.35 Death DANAMI-2: Results Lytic Primary PCI P=0.15 Stroke Lytic Primary PCI P< Recurrent MI

Door-to-Balloon Time (minutes) <1 / month N=4,740 P = <1 / month N=4,740 P = / month N=14,078 P < / month N=14,078 P < >3 / month N=14,078 P < >3 / month N=14,078 P < Primary PCI: Door-to-Balloon time vs. Mortality Stratified by Institutional Volume

13 Hospital Volume of Primary PTCA vs. Mortality P value for trend < Canto. NEJM 2000 N: Pt = 2,825 5,245 9,303 19,162 Hosp =

14 DANAMI 2 Conclusions Among patients transferred for primary PCI with a median door to balloon time of 114 minutes, the incidence of the composite endpoint of death, recurrent MI, and stroke is reduced compared with the administration of tPA and heparin when used in conjunction with a rescue / adjunctive PCI rate of 2.5%. CM Gibson 2002

15 DANAMI 2 Conclusions The median US door to balloon time for transfer patients is 198 minutes, and is not as rapid as in DANAMI 2 (114 minutes) The composite endpoint was driven primarily by a lower rate of recurrent MI among PCI patients Current strategies that employ higher rates of rescue and adjunctive PCI after fibrinolysis and higher rates of enoxaparin use have been associated with lower rates of recurrent MI than that reported in DANAMI 2 CM Gibson 2002

Cath lab at NE Baptist was activated and patient transported to NE Baptist. Patient left NE Methodist at 10:24 am Arrived at NE Baptist at 10:33 am Patient taken directly to the cath lab.

Access obtained in right CFA at 10:51 am Aspiration thrombectomy done at 11:07 RCA stented at 11:16 am with TIMI 3 flow and patient was chest pain free

73 Door to balloon from NEM door to balloon – 73 minutes 34 Door to balloon at NEB – 34 minutes 85 EKG in field to balloon time – 85 minutes call to balloon time – 94 minutes Great Job Guys !!!! Great Job Guys !!!!